{"id":"W2563072979","doi":"10.1016/s1525-0016(16)33457-8","title":"649. Developing FGFR4 Chimeric Antigen Receptor CAR T Cell Therapy Against Rhabdomyosarcoma","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fibroblast growth factor receptor 4; Immunohistochemistry; Molecular biology; Cancer research; Biology; Fusion protein; Antibody; Receptor; Fibroblast growth factor receptor; Recombinant DNA; Immunology; Fibroblast growth factor; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005097876,0.0005083609,0.0006357825,0.0003260144,0.00017812,0.00006198081,0.0004894232,0.0002429884,0.003313149],"category_scores_gemma":[0.00003694654,0.0003448826,0.0004038685,0.0006646606,0.0002221691,0.0001156266,0.0000767095,0.0003327588,0.0006449829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002788861,"about_ca_system_score_gemma":0.0004192757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004797888,"about_ca_topic_score_gemma":0.000001731755,"domain_scores_codex":[0.996572,0.0003194987,0.0004756053,0.0007861461,0.0008886766,0.0009580624],"domain_scores_gemma":[0.998018,0.0001204779,0.000140718,0.001127046,0.0002519695,0.0003417566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000674859,0.0001566445,0.002389092,0.00001297497,0.0002155434,0.0001192151,0.0002387452,6.786605e-7,0.7024934,0.00004989136,0.0005784829,0.2930705],"study_design_scores_gemma":[0.005286449,0.0004947323,0.002448465,0.00008601561,0.000005606027,0.00002239642,0.00004121539,0.000006857954,0.6802543,0.00008886665,0.3108921,0.000372967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755724,0.008364363,0.003976962,0.004195774,0.0003050322,0.001372207,0.00001203347,0.0002461135,0.00595509],"genre_scores_gemma":[0.9396218,0.0359074,0.005072795,0.007263597,0.0005059172,0.0001873625,0.00006331286,0.0003543657,0.01102343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3103137,"threshold_uncertainty_score":0.9999003,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0269789725639087,"score_gpt":0.2925045110461414,"score_spread":0.2655255384822328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}